Abstract:Objective: To evaluate the clinical therapeutic effects and safety on infertility of polycystic ovary syndrome (PCOS) in the patients with ovulation induction with letrozole in the treatment with the formula for regulating menstruation and removing phlegm and electroacupuncture (EA). Methods: A total of 120 patients of PCOS infertility were randomized into 3 groups, 40 cases in each one. In the group A, diane-35 was prescribed for oral administration (one tablet a day since the 5th day of menstruation, continuously for 21 days). After 1 course of treatment (3 months), letrozole was used (one tablet a day since the 5th day of menstruation, continuously for 5 days) for ovulation induction for another 1 course (3 months). In the group B, on the basis of the treatment as the group A, since the 5th day of menstruation, the Chinese herbal formula was combined to regulate menstruation and remove phlegm, one dose a day and discontinued during menstruation. In the group C, on the basis of the treatment as the group B, EA was added since the 5th day of menstruation. The main acupoints were Guanyuan (CV 4), Zusanli (ST 36) and Fenglong (ST 40), etc. EA was applied once every 2 days and discontinued during menstruation. In all of the 3 groups, the treatment for 3 months was as 1 course and the 2 courses were required continuously. Before and after treatment, the menstruation improvements, body weight, body mass index (BMI), serum sex hormones [luteal production hormone (LH), follicle stimulating hormone (FSH), LH/FSH, total testosterone (T) and estradiol (E2)] were observed in the patients of each group. The enzyme linked immunosorbent assay was adopted to determine the content of anti-mullerian hormone (AMH) and inhibin B (IHNB). The therapeutic effects, safety, ovulation rate and pregnancy rate were compared among the 3 groups. Results: (1) The differences were significant statistically in the total effective rate, ovulation rate and pregnancy rate in comparison of the 3 groups (all P<0.05). The results in the group C were the best and those in the group B were the better in the comparison of the 3 groups. (2) After treatment, the menstrual cycle was remarkably shortened in the 3 groups (all P<0.05). The result in the group C was better than that in the group A (P<0.05). After treatment, the body weight in the group B and group C was all reduced (both P<0.05). The reducing degree in the group C was better than that in the group A (P<0.05). The differences in BMI were not significant statistically before and after treatment in each group as well as in comparison among the groups (all P>0.05). (3) After treatment, the levels of LH and LH/FSH were all reduced remarkably in the 3 groups (all P<0.05). The differences were not significant statistically in comparison among the three groups (all P>0.05). After treatment, in the group B and group C, the levels of T and AMH were all reduced remarkably (all P<0.05), in which, T value in the group C was lower than that in the group A and group B, that in the group B was lower than the group A (all P<0.05). AMH value in the group C was lower than that in the group A (P<0.05). The differences were not significant statistically in FSH, E2 and IHNB before and after treatment in each group as well as in comparison among the 3 groups (all P>0.05). (4) The luteinized unreuptured follicle syndrome (LUFS) did not happen in the group C. There were 3 cases of LUFS (7.5%) in the group B and 5 cases (12.5%) in the group A. Conclusion: For PCOS infertility patients receiving ovulation induction with letrozole, the combined treatment with the Chinese herbal formula for regulating menstruation and removing phlegm and EA remarkably improves the menstrual cycle, reduces body weight and the levels of LH, LH/FSH, T and AMH, improves ovulation and pregnancy rates. This therapy does not induce adverse reactions and the therapeutic effects are better than the simple application of letrozole or the combined therapy of letrozole and Chinese herbal medicine.

Efifcacy of Letrozole treatment after Drospirenone and ethinylestradiol tablets pretreatment in infert-ility patients with polycystic ovary syndrome

Comparison the Effectiveness and Safety of Letrozolestimulated and Hormone Replacement Treatment in Endometrial Preparation for Frozen Embryo Transfer in Patients with Polycystic Ovary Syndrome

Letrozole Stimulation in Endometrial Preparation for Cryopreserved–thawed Embryo Transfer in Women with Polycystic Ovarian Syndrome: A Pilot Study

Clinical observation of drospirenone and ethinylestradiol tablets combined with metformin in the pretreatment of polycystic ovary syndrome

Analysis of the Effect of Letrozole Tablets Combined with Menotrophin in the Treatment of Infertility of Polycystic Ovary Syndrome

Evaluation of effectiveness of Letrozole in treatment of infertility in women with polycystic ovary syndrome

Clinical application of letrozole in ovulation induction for women with polycystic ovary syndrome

The Effects of Letrozole and Metformin Combined with Targeted Nursing Care on Ovarian Function, LH, and FSH in Infertile Patients with Polycystic Ovary Syndrome

The Efficacy of Letrozole Co-Treatment in an Antagonist Protocol for Women with Polycystic Ovary Syndrome Undergoing IVF: A Retrospective Study

Comparison the effects of letrozole and clomiphene citrate on the endocrinological profile in women with polycystic ovarian syndrome

Clinical Observation of “kuntai Formula”for the Treatment of Polycystic Ovary Syndrome

[Clinical therapeutic effects of acupuncture combined with Chinese herbal medicine on infertility of polycystic ovary syndrome in the patients with ovulation induction with letrozole]

Analysis of individualized letrozole therapy for polycystic ovary syndrome patients resistant to clomiphene

Application of Letrozole Inhibitors in Polycystic Ovary Syndrome Receiving Gonadotropin-Releasing Hormone Antagonist Protocols

Successive and Cyclic Oral Contraceptive Pill Pretreatment Improves IVF/ICSI Outcomes of PCOS Patients and Ameliorates Hyperandrogenism and Antral Follicle Excess.

Assessment of Fertility Outcomes Following Combined Clomiphene and Letrozole Versus Letrozole Therapy for the Treatment of Polycystic Ovarian Syndrome Subfertility

The efficacy of Fuke Qianjin tablets combined with clomiphene citrate on infertility patients with polycystic ovary syndrome: A retrospective analysis

A study about the effect of letrozole in ovulation induction in ovulatory infertile women-a comparison with clomiphene citrate

Effects of letrozole alone or in combination with gonadotropins on ovulation induction and clinical pregnancy in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials

Letrozole for Ovulation Induction in Women with Polycystic Ovarian Syndrome: A Systematic Analysis

Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women with PCOS: a pragmatic randomized controlled trial